tirzepatide cardiac benefits UC Irvine researchers project from weight-loss medication tirzepatide cardiac benefits An Observational

We find that at every time point assessed in the study (3, 6, 9 and 12 months) following GLP-1 initiation, the GLP-1 treatment cohort achieved a greater magnitude of total weight loss and HbA1C reduction, and a greater proportion of those taking GLP-1s achieved outcomes such as 5%, 10% and 15% weight loss at each follow-up point, as compared to controls

10.1016/j.bcp.2005.11.003 Biochem

Human clinical trial data for Dihexa remain limited

Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study

We could see even more potential benefits in the coming years, if the last decade or so of Glutathione discoveries are indicative of its progress forward

Ipamorelin Ipamorelin is a growth hormone secretagogue that may support body composition without dramatically affecting cortisol levels